Vetsys Pharmaceutical
Vetsys Pharmaceutical
The agricultural landscape of Uzbekistan is undergoing a profound transformation. As a central pillar of the nation's economy, the livestock sector accounts for a significant portion of the agricultural GDP. With the government's "Strategy for the Development of Agriculture of the Republic of Uzbekistan for 2020-2030," there is an unprecedented focus on increasing productivity, enhancing animal health standards, and adopting AI-driven and technologically advanced pharmaceutical interventions.
In regions like Samarkand, Kashkadarya, and Tashkent, the demand for high-efficacy veterinary drugs is skyrocketing. Traditional treatment methods are being replaced by Sustained-release Boluses, which offer a scientific approach to long-term disease management and nutritional supplementation. As a leading supplier and exporter, Zhengzhou Vetsys is at the forefront of this transition, bridging the gap between Chinese pharmaceutical innovation and the practical needs of Uzbek farmers.
Unlike traditional oral medications that result in rapid spikes and drops in blood concentration, our sustained-release boluses utilize a specialized polymer matrix. This allows for a controlled, steady release of active ingredients (such as Amoxicillin or Oxytetracycline) over an extended period. For Uzbek pastoralists managing large herds in remote areas, this means fewer interventions and reduced labor costs.
Uzbekistan’s continental climate—characterized by hot summers and cold winters—places immense physiological stress on livestock. Our boluses are engineered to remain stable under varying thermal conditions, ensuring that the bioavailability remains consistent, whether in the Fergana Valley or the arid Kyzylkum desert regions.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Technological innovation is our core differentiator. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health globally, with a specific focus on the Uzbekistan export market.
In high-density dairy farms, preventing mastitis and postpartum infections is critical. Our sustained-release Amoxicillin boluses provide prophylactic protection, ensuring that milk yields remain high and cows recover quickly without the need for daily injections.
The unique Karakul sheep are a national treasure. Protecting them from internal parasites is vital for wool quality. Our Fenbendazole boluses offer long-term anthelmintic eradication, crucial for sheep grazing in vast, semi-arid pastures.
With the rise of large-scale beef fattening complexes, respiratory diseases (BRD) can spread quickly. Sustained-release Oxytetracycline serves as a cornerstone for systemic infection control, maintaining herd health and growth rates.
The future of veterinary medicine in Uzbekistan is inextricably linked to sustainability and precision. As the country seeks to export more meat products to the EAEU and China, compliance with international drug residue standards is paramount. Zhengzhou Vetsys supports this through:
Our vision is to remain the Authoritative Expert and Reliable Partner for the Uzbekistan animal health industry, driving value through innovation and world-class quality management.
